| 2024/04/26 22:30:00 | |
|---|---|
| Price | |
| 0.9301 USD | |
| Difference | -1.61% (-0.02) |
General attributes
| ISIN | US00430H2013 |
| Symbol | AXDX |
| Exchange | Nasdaq |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 19 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 0.8803 USD (1,200) |
| Ask (Ask size) | 0.9933 USD (7,400) |
| Open | 0.92 USD |
| High | 0.945 USD |
| Low | 0.8854 USD |
| Close (prev. day) | 0.9453 USD |
| VWAP | 0.927193 USD |
| Volume (pcs) | 4,924 |
| Trading volume | 4,579.84 |
| Number of trades | 101 |
| Last size | - |
Futures and Options
| Related Futures | - |
| Related Options | - |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/04/26 22:30:00 | |
|---|---|
| Price | |
| 0.9301 USD | |
| Difference | -1.61% (-0.02) |
General attributes
| ISIN | US00430H2013 |
| Symbol | AXDX |
| Exchange | Nasdaq |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 19 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 0.8803 USD (1,200) |
| Ask (Ask size) | 0.9933 USD (7,400) |
| Open | 0.92 USD |
| High | 0.945 USD |
| Low | 0.8854 USD |
| Close (prev. day) | 0.9453 USD |
| VWAP | 0.927193 USD |
| Volume (pcs) | 4,924 |
| Trading volume | 4,579.84 |
| Number of trades | 101 |
| Last size | - |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -84.70% | -89.67% | -98.89% |
| Perf (abs.) | -5.15 | -8.07 | -82.57 |
| Beta | -0.80 | 0.17 | 1.11 |
| Volatility | 109.94 | 99.94 | 119.78 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 0.9288 USD (37,608) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 0.9141 USD (69,821) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 1.9778 USD (101,311) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 4.7893 USD (54,057) |
| YTD High | date | 4.2400 USD (2024/01/02) |
| YTD Low | date | 0.7300 USD (2024/04/18) |
| 52 Weeks High | date | 11.9000 USD (2023/06/12) |
| 52 Weeks Low | date | 0.7300 USD (2024/04/18) |
All listings for ACCELERATE DIAGNOSTICS INC.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Tradegate | 2024/04/26 | 22:26 | 0.88 EUR | 0.00 | 3 |
| Stuttgart | 2024/04/26 | 10:32 | 0.88 EUR | 0.00 | 4 |
| Nasdaq | 2024/04/26 | 22:30 | 0.9301 USD | 0.00 | 101 |
| London Stock Exchange | 2021/03/30 | 15:30 | 80.00 USD | 0.00 | 1 |
| Frankfurt | 2024/04/26 | 08:02 | 0.875 EUR | 0.00 | 2 |
| Duesseldorf | 2023/07/11 | 19:30 | 6.70 EUR | 0.00 | 5 |
| Berlin | 2024/04/26 | 08:08 | 0.88 EUR | 0.00 | 2 |
Company Logo
Contact Details
| ACCELERATE DIAGNOSTICS |
| - - |
| 303 E. 17th Ave., Suite 108 - - U.S.A. - Denver, CO 80203-9725 |
| Telefon: +1 - 303 - 863 - 8088 |
| Fax: +1 - 303 - 863 - 1218 |
| E-mail: info@accelr8.com |
Company Profile
| - |